A Study to Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 Years
NCT02263469
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
OTHER
Sponsor class
Conditions
Haemophilia B
Interventions
BIOLOGICAL:
Replenine®-VF (High Purity Factor IX)
Sponsor
Bio Products Laboratory